ims-health
(2)
Robert Chu
Robert Chu is the co-founder and CEO of Embleema, a New York-based clinical research platform that collects and generates regulatory-grade evidence to accelerate precision medicine. He founded the company in 2017 after nearly three decades in enterprise technology and life sciences data, including roles as Senior Vice President of Global Technology Solutions at IQVIA (formerly QuintilesIMS), where he ran a 1,400-person, $800M SaaS business, and prior leadership positions at IMS Health in France, China, and Asia Pacific, following 15+ years at IBM. Trained as an engineer at Ecole Polytechnique in Paris, he now works at the intersection of patient consent, blockchain, and clinical data collection, with Embleema partnering with pharma sponsors and the FDA on real-world evidence workflows.
Andrew Kress
Andrew Kress is the co-founder and CEO of HealthVerity, the Philadelphia company that built one of the largest real-world healthcare data ecosystems and the technology to link, govern and exchange it without exposing patient identities. An English major from Yale who spent his career inside the plumbing of healthcare data - running SDI Health, then leading Healthcare Value Solutions at IMS Health - he started HealthVerity in 2014 to make fragmented, privacy-bound health data usable. The company raised $100M in Series D funding in 2021 led by Durable Capital Partners. Kress also serves on the boards of Philadelphia cultural institutions including the Pennsylvania Academy of the Fine Arts.